Deal Snapshot
ELLIGO HEALTH RESEARCH ACQUIRES PROTENIUM CLINICAL RESEARCH
Friday 11 January 2019

US-based integrated research organisation Elligo Health Research has acquired Protenium Clinical Research, the company said.
Protenium, an established research group led by Robert Strzinek, Ph.D., D.O., conducts pharmaceutical studies in a broad range of therapeutic areas. Strzinek has more than 15 years of clinical research experience and will now conduct research at his practice in partnership with Elligo.


TKUqg0 http://www.FyLitCl7Pf7kjQdDUOLQOuaxTXbj5iNG.com
Details
Date Published: 11/01/2019
Target: Protenium Clinical Research
Country: USA
Sector: Healthcare
Type: Corporate acquisition
Financing:
Status: Closed
Vendor:
Buyer: Elligo Health Research
Comment:
Terms of the deal were not disclosed

Options